정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1472 | Recruiting | Estradiol and Progesterone in Hospitalized COVID-19 Patients | Covid19 | Other: Placebo injection and placebo pill Drug: Estradiol Cypionate 5 MG/ML Drug: Progesterone 200 MG Oral Capsule |
Phase 2 | Tulane University | OTHER | 120 | All | 18 Years | Tulane University Medical Center, New Orleans, Louisiana, United States |
| 1471 | Recruiting | Estrogen Patch for COVID-19 Symptoms | COVID | Drug: Estradiol patch | Phase 2 | Sharon Nachman | OTHER | 110 | All | 18 Years | Stony Brook University Hospital, Stony Brook, New York, United States |
| 1470 | Recruiting | Estrogen Therapy in Non-severe COVID-19 Patients | Covid-19 | Drug: Estrogen Therapy | Not Applicable | CMN "20 de Noviembre" | OTHER | 60 | All | 18 Years ~ 70 Years | CMN "20 de Noviembre", Mexico City, Benito Juarez, Mexico |
| 1469 | Active, not recruiting | Etoposide in Patients With COVID-19 Infection | COVID-19 | Drug: Etoposide | Phase 2 | Boston Medical Center | OTHER | 8 | All | 18 Years | Boston Medical Center, Boston, Massachusetts, United States |
| 1468 | Recruiting | EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial | Emerging Infectious Disease | Drug: Baricitinib Drug: Placebo |
Phase 3 | Oslo University Hospital, Institut National de la Sante Et de la Recherche Medicale, France, Epidemiological and Clinical Research Information Network | OTHER | 1900 | All | 18 Years | Medical University of Innsbruck (University Hospital for Neurosurgery), Innsbruck, Austria Medical Unversity of Innsbruck (Joint Institute for Emergency Medicine and Critical Care), Innsbruck, Austria Medical Unversity of Innsbruck (University Hospital for Anaesthesia and Intensive Care), Innsbruck, Austria Erasme Hospital, Brussels, Belgium UZ Brussel, Brussels, Belgium Cliniques Universitaires Saint-Luc, Brussels, Belgium CHU Saint-Pierre, Brussel, Belgium St Anne University Hospital, Brno, Czechia CHU Amiens Picardie (ICU), Amiens, France CHU Amiens Picardie (ID), Amiens, France CHU de Bordeaux / Hopital Pellegrin (ICU), Bordeaux, France CHU de Bordeaux / Hopital Pellegrin (ID), Bordeaux, France Louis Mourier (ID), Colombes, France Lous Mourier (ICU), Colombes, France CHU Francois Mitterrand, Dijon, France CHU Lille - Hopital Roger Salengro -Pole Reanimaition, Lille, France Hopital de la Croix - Rousse - HCL (ICU), Lyon, France Hopital de la Croix - Rousse - HCL (ID), Lyon, France GHRMSA Hopital Emile Muller (ICU), Mulhouse, France GHRMSA Hopital Emile Muller (IM), Mulhouse, France Hopital Saint-Antoine (ICU), Paris, France Hopital Saint-Antoine (ID), Paris, France Hopital Bichat - Claude Bernard (ICU), Paris, France Hopital Bichat - Claude Bernard (ID), Paris, France Gesundheit Nord gGmbH (GeNo), Bremen, Germany Justus-Leibig Universitat (JLU), Geißen, Germany Medizinische Hochschule Hannover (MHH), Hannover, Germany Technische Universitat Munchen (TUM) - Klinikum rechts der Isar, Munchen, Germany Klinikum Saarbrucken gGmbH (SAAR), Saarbrucken, Germany Evangelismos Hospital, Athens, Greece Attikon University Hospital, Athens, Greece University of Debrecen (Clinic for Infectology), Debrecen, Hungary University of Pecs, Pecs, Hungary University of Szeged (Pandemic Clinics), Szeged, Hungary Cork University Hospital, Cork, Ireland St Vincent's University Hospital, Dublin, Ireland Mater Misericordiae University Hospital, Dublin, Ireland St James's Hospital, Dublin, Dublin, Ireland Beaumont Hospital, Dublin, Dublin, Ireland Tallaght University Hospital, Dublin, Ireland University Hospital Galway, Galway, Ireland University Hospital Limerick, Limerick, Ireland Ospedale Cardinal Massala di Asti, Malattie Infettive, Asti, Italy Ospedale Santa Maria Annunziata, Malattie Infettive, Bagno A Ripoli, Italy ASST - Spedali Civili di Brescia - University of Brescia, Brescia, Italy ATS Sardegna - PO SS Trinita, U.O.C. Malattie Infettive, Cagliari, Italy Azienda Opsedaliera Universitaria Mater Domini, U.O. Malattie Infettive e Tropicali, Catanzaro, Italy ASL Frosinone - Ospedale Fabrizio Spaziani, U.O.C. Medicina Interna, Frosinone, Italy Ospedale S.M. Goretti di Latina, U.O.C. Malattie Infettive, Latina, Italy Ospedale Mater Salutis di Legnago, U.O.C. di Pneumologia, Legnano, Italy Ospedale Mater Salutis di Legnago, U.O.S. di Malattie Infettive, Legnano, Italy Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, U.O.C. Malattie Infettive, Milano, Italy ASST Santi Paolo e Carlo, S.C. Malattie Infettive, Milano, Italy Azienda Ospedaliera Universitaria Vanvitelli, U.O.C. Malattie Infettive, Napoli, Italy AOU Policlinico "P. Giaccone", U.O.C. Malattie Infettive, Palermo, Italy Azienda Ospedaliera Ospedali Riuniti Marche Nord, U.O.C. Malattie Infettive, Pesaro, Italy ASL Taranto - Ospedale Oncologico San Giuseppe Moscati, U.O.C. Pneumologia, Taranto, Italy Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI), S.C. Malattie Infettive, Trieste, Italy IRCCS Ospedale Sacro Cuore Don Calabria, U.O.S. Malattie Infettive e Tropicali, Verona, Italy Azienda Ospedaliera Universitaria Integrata di Verona, U.O.C. Malattie Infettive e Tropicali, Verona, Italy Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg Haukeland University Hospital, Bergen, Norway Drammen (Vestre Viken) Hospital, Drammen, Norway Østfold sykehuset i Kalnes, Gralum, Norway Akershus Universitetssykehus, Lørenskog, Norway Lovisenberg Diaconal Hospital, Oslo, Norway OUS Ulleval, Oslo, Norway Bærum Hospital, Sandvika, Norway Stavanger University Hospital, Stavanger, Norway University Hospital North Norway, Tromsø, Norway St. Olavs Hospital, Trondheim, Norway Vestfold Hospital, Tønsberg, Norway CHMT - Centro Hospitalar do Medio Tejo- Hospital de Abrantes, Abrantes, Portugal CHUC - Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal CHUA-Faro - Centro Hospitalar Universitario do Algarve, Faro, Portugal CHLC-HCC - Hospital Curry Cabral, Centro Hospitalar Universitario Lisboa Central, Lisboa, Portugal CHLN - Centro Hospitalar Universitario Lisboa Norte, Lisboa, Portugal CHLO - Centro Hospitalar de Lisboa Ocidental - HEM and HSFX, Lisbon, Portugal CHSJ - Sao Joao Hospital Center, Lisbon, Portugal HBA - Hospital Beatriz Angelo, Loures, Portugal University Hospital Bratislava, Kramare, Bratislava, Slovakia University Hospital Martin, Martin, Slovakia Nsp Trebisov, Svet Zdravia a.s., Trebi?ov, Slovakia Faculty Hospital Trencin, Tren?in, Slovakia University Hospital Trnava, Trnava, Slovakia Nemocnica AGEL Ko?ice-?aca a.s., ?aca, Slovakia Hospital Universitario Reina Sofia, Cordoba, Spain Hospital Universitario de Jaen, Jaen, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Costa del Sol, Marbella, Spain Hospital Virgen de la Victoria, Malaga, Spain Hospital Universitario Virgen Macarena, Sevilla, Spain Hospital Universitario Virgen del Rocio, Sevilla, Spain Hospital Universitario Virgen de Valme, Sevilla, Spain Hacettepe Universitesi Tıp Fakultesi, ?nfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı (Site 1), Ankara, Turkey Hacettepe Universitesi Tıp Fakultesi, ?nfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı (Site 2), Ankara, Turkey Ankara Universitesi Tıp Fakultesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Ankara, Turkey ?stanbul Universitesi ?stanbul Tıp Fakultesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, Istanbul, Turkey Dokuz Eylul Universitesi Tıp Fakultesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı, ?zmir, Turkey |
| 1467 | Not yet recruiting | Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers | COVID 19 | Drug: HLX70 Other: Placebo |
Phase 1 | Hengenix Biotech Inc, Sanyou Biopharmaceuticals(Shanghai)Co., Ltd, Shanghai ZJ Bio-Tech Co., Ltd | INDUSTRY | 24 | All | 18 Years ~ 60 Years | |
| 1466 | Recruiting | Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 | COVID-19 | Drug: Hydroxychloroquine Drug: Indomethacin Drug: Zithromax Oral Product |
Phase 2 | Perseverance Research Center, LLC, Athena Medical Group | OTHER | 80 | All | 18 Years | Perseverance Research Center, Scottsdale, Arizona, United States Covidcraz 19, Llc, New Orleans, Louisiana, United States |
